Skip to main content
H.Res. 1175 House Congress

Providing for consideration of the bill (H.R. 8035) to amend the FISA Amendments Act of 2008 to extend the authorities of title VII of the Foreign Intelligence Surveillance Act of 1978 through October 20, 2027, and for other purposes.

Introduced
Apr 15, 2026
Sponsor
Rep. Scott, Austin (R-GA-8)
View on Congress.gov (opens in a new tab)

STAGE 4 OF 8 — HOUSE FLOOR

Currently in the House. Last action: motion to reconsider laid on the table agreed to without objection on Apr 17, 2026.

  1. House The House Committee on Rules reported an original measure, H. Rept. 119-610, by Mr. Scott, Austin. Apr 15, 2026
  2. House Rule provides for consideration of H.R. 8035 with 1 hour of general debate. Motion to recommit allowed. Bill is closed to amendments. Apr 15, 2026
  3. House Placed on the House Calendar, Calendar No. 71. Apr 15, 2026
  4. House Considered as privileged matter. (consideration: CR H2948-2955; text: CR H2948) Apr 16, 2026
  5. House Considered as privileged matter. Apr 16, 2026
  6. House DEBATE - The House proceeded with one hour of debate on H. Res. 1175. Apr 16, 2026
  7. House Failed of passage/not agreed to in House On agreeing to the resolution Failed by recorded vote: 197 - 228 (Roll no. 124). Apr 17, 2026
  8. House On agreeing to the resolution Failed by recorded vote: 197 - 228 (Roll no. 124). Apr 17, 2026
  9. House Motion to reconsider laid on the table Agreed to without objection. Apr 17, 2026
  10. House Latest vote
    On Agreeing to the Resolution Apr 17, 2026
    Defeated Yea 197 Nay 228 Roll Call

Subjects

House of RepresentativesLegislative rules and procedure

Committees

  • Rules Committee
    • Reported Original Measure , Apr 15, 2026

Summary

This resolution provides for the consideration of the bill (H.R. 8035) to amend the FISA Amendments Act of 2008 to extend the authorities of title VII of the Foreign Intelligence Surveillance Act of 1978 through October 20, 2027, and for other purposes.

Summary as of: Reported to House

Comments · 0

Loading...

Loading comments...